id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2167-0008,FDA,FDA-2020-E-2167,NOTICE OF FINAL DETERMINATION AND REQUIREMENT FOR ELECTION,Other,Letter(s),2024-08-19T04:00:00Z,2024,8,2024-08-19T04:00:00Z,,2024-08-19T15:15:43Z,,0,0,090000648662133b
FDA-2020-E-2167-0007,FDA,FDA-2020-E-2167,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,,2022-08-29T16:04:14Z,,0,0,0900006485286661
FDA-2020-E-2167-0006,FDA,FDA-2020-E-2167,Determination of Regulatory Review Period for Purposes of Patent Extension; QINLOCK,Notice,Determinations,2021-11-16T05:00:00Z,2021,11,2021-11-16T05:00:00Z,2022-01-19T04:59:59Z,2021-11-16T18:16:22Z,2021-24978,0,0,0900006484e4dfcd
FDA-2020-E-2167-0005,FDA,FDA-2020-E-2167,Patent Term Extension letter from FDA CDER to The Honorable Drew Hirshfield,Other,Letter(s),2021-11-05T04:00:00Z,2021,11,2021-11-05T04:00:00Z,,2021-11-05T15:06:14Z,,0,0,0900006484e2593f
FDA-2020-E-2167-0004,FDA,FDA-2020-E-2167,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-10-14T04:00:00Z,2021,10,2021-10-14T04:00:00Z,,2021-10-14T17:22:40Z,,0,0,0900006484dc58e0
FDA-2020-E-2167-0003,FDA,FDA-2020-E-2167,Letter to U S Patent and Trademark Office,Other,Letter(s),2020-12-14T05:00:00Z,2020,12,2020-12-14T05:00:00Z,,2020-12-14T15:48:42Z,,0,0,090000648499ca83
FDA-2020-E-2167-0001,FDA,FDA-2020-E-2167,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-11-05T05:00:00Z,2020,11,2020-11-05T05:00:00Z,,2020-11-05T14:23:27Z,,0,0,090000648494c3d4
FDA-2020-E-2167-0002,FDA,FDA-2020-E-2167,"Patent Term Extension Application for QINLOCK® Patent No 8,188,113",Other,Application,2020-11-05T05:00:00Z,2020,11,2020-11-05T05:00:00Z,,2020-11-05T14:25:53Z,,0,0,090000648494c3d5